About this file

This document is a Notice of Intent to Sole Source issued by the Food and Drug Administration (FDA) for the purchase of a Controller Computer and Software for Sciex Liquid Chromatograph-Triple Quadrupole Mass Spectrometers.

The FDA intends to award a sole source contract to AB SCIEX LLC for this requirement, with an estimated value of less than $165,000. AB SCIEX LLC is identified as the sole-source service provider for this equipment and software. The FDA will consider any information received for the purpose of determining whether to conduct a competitive procurement. Questions or comments on this notice should be directed to the Contract Specialist, Courtney Black, via email within 7 days of the posting date. No phone calls or voicemails will be accepted. This is not a request for quotes or proposals.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

NOTICE OF INTENT TO SOLE SOURCE

Project Title: Controller and Software for Sciex LC Triple Quad MS Announcement No: FDA-2024-121798 The Government hereby submits a notice of intent to award a sole source contract to AB SCIEX LLC for Controller and Software for Sciex LC Triple Quad MS total estimated value is less than 165K This sole source contracting action is a notice pursuant to FAR 5.203(a) for the requirement based on the application of FAR 6.302-1. This hereby constitutes a synopsis of this requirement.

This is an award under NAICS Code 334516. AB SCIEX LLC is the sole-source service provider for Controller and Software for Sciex LC Triple Quad MS.

The determination not to compete this proposed contract action solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice.

This is NOT a request for quotes or proposals.

Questions or comments to this Notice of Intent should be directed to Contract Specialist, Courtney Black, at Courtney.Black@fda.hhs.gov (via email only) and within 7 days of the notice of intent posting date. Please be advised no phone calls/voice mail messages regarding questions will be accepted and nor will they receive a response). Please indicate in the subject line of your email: Notice of Intent Questions Submission – FDA-2024-121798

File details come from the government source that posted it. Updated .